Status:
COMPLETED
Role of Mega Dose of Vitamin C in Critical COVID-19 Patients
Lead Sponsor:
University of Lahore
Conditions:
Corona Virus Infection
Eligibility:
All Genders
Phase:
NA
Brief Summary
Vitamin C (ascorbic acid) is a water-soluble vitamin having anti-inflammatory, immunomodulatory, anti-oxidative, antithrombotic and antiviral properties. Considering these effects vitamin C should hav...
Eligibility Criteria
Inclusion
- critically ill patients admitted in ICU
Exclusion
- allergic to Vitamin C didnt given the consent
Key Trial Info
Start Date :
November 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2022
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT04682574
Start Date
November 2 2020
End Date
March 10 2022
Last Update
May 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bahria Town International Hospital
Lahore, Punjab Province, Pakistan, 54000